AU2803289A - Method of using fluorocarbons in nuclear magnetic resonance imaging - Google Patents
Method of using fluorocarbons in nuclear magnetic resonance imagingInfo
- Publication number
- AU2803289A AU2803289A AU28032/89A AU2803289A AU2803289A AU 2803289 A AU2803289 A AU 2803289A AU 28032/89 A AU28032/89 A AU 28032/89A AU 2803289 A AU2803289 A AU 2803289A AU 2803289 A AU2803289 A AU 2803289A
- Authority
- AU
- Australia
- Prior art keywords
- fluorocarbons
- magnetic resonance
- nuclear magnetic
- resonance imaging
- imaging
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
- G01R33/48—NMR imaging systems
- G01R33/54—Signal processing systems, e.g. using pulse sequences ; Generation or control of pulse sequences; Operator console
- G01R33/56—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
- G01R33/5601—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution involving use of a contrast agent for contrast manipulation, e.g. a paramagnetic, super-paramagnetic, ferromagnetic or hyperpolarised contrast agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
- A61K49/1806—Suspensions, emulsions, colloids, dispersions
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11407587A | 1987-10-27 | 1987-10-27 | |
US114075 | 1987-10-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2803289A true AU2803289A (en) | 1989-05-23 |
Family
ID=22353231
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU28032/89A Abandoned AU2803289A (en) | 1987-10-27 | 1988-10-27 | Method of using fluorocarbons in nuclear magnetic resonance imaging |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2803289A (en) |
WO (1) | WO1989003693A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU641233B2 (en) * | 1990-02-21 | 1993-09-16 | Board Of Regents, The University Of Texas System | 19F labelled compounds as NMR imaging and spectroscopy agents |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4951673A (en) * | 1988-08-19 | 1990-08-28 | Alliance Pharmaceutical Corp. | Magnetic resonance imaging with perfluorocarbon hydrides |
US5318770A (en) * | 1991-10-25 | 1994-06-07 | Mallinckrodt Medical, Inc. | Trifluoromethyl analogs of X-ray contrast media for magnetic resonance imaging |
GB9216843D0 (en) * | 1992-08-07 | 1992-09-23 | Cancer Res Inst | Contrast agents for medical imaging |
US6753006B1 (en) | 1993-02-22 | 2004-06-22 | American Bioscience, Inc. | Paclitaxel-containing formulations |
US5665382A (en) * | 1993-02-22 | 1997-09-09 | Vivorx Pharmaceuticals, Inc. | Methods for the preparation of pharmaceutically active agents for in vivo delivery |
US5362478A (en) * | 1993-03-26 | 1994-11-08 | Vivorx Pharmaceuticals, Inc. | Magnetic resonance imaging with fluorocarbons encapsulated in a cross-linked polymeric shell |
US5650156A (en) * | 1993-02-22 | 1997-07-22 | Vivorx Pharmaceuticals, Inc. | Methods for in vivo delivery of nutriceuticals and compositions useful therefor |
US5660815A (en) * | 1995-04-28 | 1997-08-26 | Molecular Biosystems, Inc. | Water soluble fluorinated fatty acid sulfonate derivatives useful as magnetic resonance imaging agents |
US7030208B2 (en) | 2002-04-11 | 2006-04-18 | Carbomer, Inc. | Biocompatible materials and probes |
CN114098699A (en) * | 2021-11-05 | 2022-03-01 | 中国科学院精密测量科学与技术创新研究院 | Experiment bed for magnetic resonance perfusion imaging of small animals |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4639364A (en) * | 1984-11-14 | 1987-01-27 | Mallinckrodt, Inc. | Methods and compositions for enhancing magnetic resonance imaging |
-
1988
- 1988-10-27 WO PCT/US1988/003830 patent/WO1989003693A1/en unknown
- 1988-10-27 AU AU28032/89A patent/AU2803289A/en not_active Abandoned
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU641233B2 (en) * | 1990-02-21 | 1993-09-16 | Board Of Regents, The University Of Texas System | 19F labelled compounds as NMR imaging and spectroscopy agents |
Also Published As
Publication number | Publication date |
---|---|
WO1989003693A1 (en) | 1989-05-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0318212A3 (en) | Magnetic resonance imaging methods and apparatus | |
EP0306135A3 (en) | Magnetic resonance imaging methods and apparatus | |
ZA886934B (en) | Perfluoro-crown ethers in fluorine magnetic resonance imaging | |
DE3572037D1 (en) | Nuclear magnetic resonance imaging apparatus | |
AU4341289A (en) | Methods and compositions for magnetic resonance imaging | |
EP0408345A3 (en) | Methods of and apparatus for magnetic resonance imaging | |
AU2803289A (en) | Method of using fluorocarbons in nuclear magnetic resonance imaging | |
EP0204320A3 (en) | Magnetic resonance imaging method | |
GB2234594B (en) | Nuclear magnetic resonance imaging methods | |
EP0280515A3 (en) | Method of, and apparatus for, magnetic resonance imaging | |
GB2176012B (en) | Nuclear magnetic resonance imaging apparatus | |
EP0409421A3 (en) | Magnetic resonance imaging methods and apparatus | |
IL90941A0 (en) | Method and apparatus for magnetic resonance tomography | |
EP0270320A3 (en) | Method of high-speed magnetic resonance imaging | |
GB2227095B (en) | Magnetic resonance imaging apparatus and method | |
DE3666632D1 (en) | Nuclear magnetic resonance imaging method | |
EP0304249A3 (en) | Magnetic resonance methods and apparatus | |
EP0394445A4 (en) | Method of limiting the region for magnetic resonance imaging | |
EP0418675A3 (en) | Nuclear magnetic resonance multi-echo imaging method and apparatus | |
IL92301A0 (en) | Magnetic resonance tomography method and apparatus | |
EP0135143A3 (en) | Imaging method and apparatus using nuclear magnetic resonance | |
GB2202335B (en) | Nuclear magnetic resonance imaging apparatus | |
EP0296834A3 (en) | Magnetic resonance imaging methods and apparatus | |
GB2190502B (en) | Nuclear magnetic resonance methods and apparatus | |
GB2234595B (en) | Nuclear magnetic resonance imaging methods |